Home   Documents   The Company    Technology & Products    Financing    Downloads    Meet us    Chronology & News 
     
  PharmEste is a private biopharmaceutical company
focused on the discovery and development of Transient Receptor Potential
(TRP) channel therapeutics for the treatment of neuropathic pain,
and other TRP-mediated diseases.
PHE377 a potential best-in class TRPV1 antagonist for the treatment of neuropathic pain
is under Phase I clinical development completion.
A second generation of TRPV1 antagonist is in preclinical development stage
and a discovery program on other TRPs is ongoing.
PharmEste Business Unit is located in Milan and Laboratories in Ferrara.
 
 
     Watch the video
  Meet us
  November 12-14, 2012
  Bio Europe 2012
Hamburg, Germany
 

 
 
 
PharmEste Business Unit: Technology Park:



Scientific-Technological Campus, Block B,
Ground Floor:

Via Ariosto 21- 20091 Bresso (Milan), Italy
Tel. +39 02 66524550; Fax +39 02 66524547
P.I. 01600600389

Via Saragat 1 - 44100 Ferrara, Italy